GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Epi Biotech Co Ltd (XKRX:446440) » Definitions » Short-Term Capital Lease Obligation

Epi Biotech Co (XKRX:446440) Short-Term Capital Lease Obligation : ₩0.00 Mil (As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is Epi Biotech Co Short-Term Capital Lease Obligation?

Epi Biotech Co's Short-Term Capital Lease Obligation for the quarter that ended in . 20 was ₩0.00 Mil.


Epi Biotech Co Short-Term Capital Lease Obligation Historical Data

The historical data trend for Epi Biotech Co's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epi Biotech Co Short-Term Capital Lease Obligation Chart

Epi Biotech Co Annual Data
Trend
Short-Term Capital Lease Obligation

Epi Biotech Co Semi-Annual Data
Short-Term Capital Lease Obligation

Epi Biotech Co Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


Epi Biotech Co Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Epi Biotech Co's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Epi Biotech Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
32, Songdogwahak-ro, Rooms 1903 and 1904, 15th floor, M-dong, Yeonsu-gu, Incheon, KOR, 21984
Epi Biotech Co Ltd is developing various pipelines for each hair loss treatment modality. It also conducts R&D in skin regeneration treatments to create commercially viable consumer products. The company specializes in hair loss treatment in Korea.

Epi Biotech Co Headlines

No Headlines